STING agonists drive intrinsic type I interferon responses in monocytes for optimal anti-tumor immunity

被引：0
|
作者：
Yu, Tianning
Girard, Melanie
Watts, Tania H.
机构：
来源：
CANCER IMMUNOLOGY RESEARCH | 2023年 / 11卷 / 12期
关键词：
D O I：
10.1158/2326-6074.TUMIMM23-A012
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A012
引用
收藏
页数：2
相关论文
共 50 条
  • [21] STING pathway as a cancer immunotherapy: Progress and challenges in activating anti-tumor immunity
    Tabar, Mohammad Mahdi Mokhtari
    Fathi, Mahnaz
    Kazemi, Fatemeh
    Bazregari, Ghazal
    Ghasemian, Abdolmajid
    MOLECULAR BIOLOGY REPORTS, 2024, 51 (01)
  • [22] mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
    Sittplangkoon, Chutamath
    Alameh, Mohamad-Gabriel
    Weissman, Drew
    Lin, Paulo J. C.
    Tam, Ying K.
    Prompetchara, Eakachai
    Palaga, Tanapat
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [23] Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response
    Xia, Xiaojun
    Mai, Junhua
    Xu, Rong
    Enrique, Jorge
    Perez, Tovar
    Guevara, Maria L.
    Shen, Qi
    Mu, Chaofeng
    Tung, Hui-Ying
    Corry, David B.
    Evans, Scott E.
    Liu, Xuewu
    Ferrari, Mauro
    Zhang, Zhiqiang
    Li, Xian Chang
    Wang, Rong-Fu
    Shen, Haifa
    CELL REPORTS, 2015, 11 (06): : 957 - 966
  • [24] Cross-dressed dendritic cells drive anti-tumor immunity
    MacNabb, Brendan
    Kline, Douglas
    Kline, Justin
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [25] Cargocytes: A novel cell therapy platform to drive anti-tumor immunity
    Klemke, Richard L.
    Wang, Huawei
    Liu, Bei
    Alarcon, Christina
    Watson, Felicia
    CANCER RESEARCH, 2019, 79 (13)
  • [26] Cargocytes: A Novel Cell Therapy Platform to Drive Anti-Tumor Immunity
    Wang, Huawei
    Alarcon, Christina N.
    Liu, Bei
    Watson, Felicia
    Klemke, Richard
    MOLECULAR THERAPY, 2019, 27 (04) : 271 - 271
  • [27] Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity
    Overacre-Delgoffe, Abigail E.
    Chikina, Maria
    Dadey, Rebekah E.
    Yano, Hiroshi
    Brunazzi, Erin A.
    Shayan, Gulidanna
    Horne, William
    Moskovitz, Jessica M.
    Kolls, Jay K.
    Sander, Cindy
    Shuai, Yongli
    Normolle, Daniel P.
    Kirkwood, John M.
    Ferris, Robert L.
    Delgoffe, Greg M.
    Bruno, Tullia C.
    Workman, Creg J.
    Vignali, Dario A. A.
    CELL, 2017, 169 (06) : 1130 - +
  • [28] Necroptosis stimulates interferon-mediated protective anti-tumor immunity
    Rucker, A. Justin
    Park, Christa S.
    Li, Qi Jing
    Moseman, E. Ashley
    Chan, Francis Ka-Ming
    CELL DEATH & DISEASE, 2024, 15 (06):
  • [29] STING activation in the tumor microenvironment with a synthetic human STING-activating cyclic dinucleotide leads to potent anti-tumor immunity
    Glickman, Laura Hix
    Kanne, David B.
    Kasibhatla, Shailaja
    Li, Jie
    Pferdekamper, AnneMarie Culazzo
    Gauthier, Kelsey Sivick
    Deng, Weiwen
    Desbien, Anthony L.
    Katibah, George E.
    Leong, Justin J.
    Sung, Leonard
    Metchette, Ken
    Ndubaku, Chudi
    Zheng, Lianxing
    Cho, Charles
    Feng, Yan
    McKenna, Jeffrey M.
    Tallarico, John A.
    Bender, Steven L.
    Dubensky, Thomas W.
    McWhirter, Sarah M.
    CANCER RESEARCH, 2016, 76
  • [30] Microbiota regulates intratumoral monocytes to promote anti-tumor immune responses
    McCoy, Kathy D.
    Geuking, Markus B.
    CELL, 2021, 184 (21) : 5301 - 5303
12345